PINION JOHN RICHARD (See Remarks) sold 8.4% of their position (10.03K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $228.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001193125-26-089287
Officer· See Remarks
Since Mar 2026
+1.11K
Net shares
Net buyer
$228.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.14K acquired · 10.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.14K
Price / share
—
Trade value
—
% of position
10.3%
3/1/2026
108.43K→119.56K
Common Stock
Direct
Shares
−10.03K
Price / share
$22.80
Trade value
$228.66K
% of position
8.4%
3/2/2026
120.06K→110.03K
Total
Net shares
+1.11K
Net value
-$228.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +11.14K | — | — | 10.3% | 108.43K | 119.56K |
| Common Stock Direct | 3/2/2026 | S · Sale | −10.03K | $22.80 | $228.66K | 8.4% | 120.06K | 110.03K |
| Total | +1.11K | -$228.66K | ||||||
Derivative Transactions0
No derivative transactions reported